BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1107519	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Plasma kallikrein	Human				 32.0					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107520	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Coagulation factor X	Homo sapiens		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	1C5M,1EZQ,1F0R,1F0S,1FAX,1FJS,1G2L,1G2M,1HCG,1IOE,1IQE,1IQF,1IQG,1IQH,1IQI,1IQJ,1IQK,1IQL,1IQM,1IQN,1KSN,1LPG,1LPK,1LPZ,1LQD,1MQ5,1MQ6,1NFU,1NFW,1NFX,1NFY,1P0S,1V3X,1WU1,1XKA,1XKB,1Z6E,2BMG,2BOH,2BOK,2BQ6,2BQ7,2BQW,2CJI,2D1J,2EI6,2EI7,2EI8,2FZZ,2G00,2GD4,2H9E,2J2U,2J34,2J38,2J4I,2J94,2J95,2JKH,2P16,2P3F,2P3T,2P3U,2P93,2P94,2P95,2PHB,2PR3,2Q1J,2RA0,2UWL,2UWO,2UWP,2VH0,2VH6,2VVC,2VVU,2VVV,2VWL,2VWM,2VWN,2VWO,2W26,2W3I,2W3K,2WYG,2WYJ,2XBV,2XBW,2XBX,2XBY,2XC0,2XC4,2XC5,2Y5F,2Y5G,2Y5H,2Y7X,2Y7Z,2Y80,2Y81,2Y82,3CEN,3CS7,3ENS,3FFG,3HPT,3IIT,3K9X,3KL6,3KQB,3KQC,3KQD,3KQE,3LIW,3M36,3M37,3Q3K,3SW2,3TK5,3TK6,4A7I,4BTI,4BTT,4BTU,4Y6D,4Y71,4Y76,4Y79,4Y7A,4Y7B,4ZH8,4ZHA,5K0H,5VOE,5VOF,7AHU,7TPP,7TPQ	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107521	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Prothrombin	Human		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	1C1U,1C1V,1C1W,1C4U,1C4V,1C4Y,1C5L,1C5N,1C5O,1CA8,1D3D,1D3P,1D3Q,1D3T,1D4P,1D6W,1D9I,1DE7,1DIT,1DOJ,1DWB,1DWC,1DWD,1DWE,1EB1,1FPC,1FPH,1G30,1G32,1G37,1GHV,1GHW,1GHX,1GHY,1GJ4,1GJ5,1HAG,1HAH,1HAI,1HAO,1HAP,1HBT,1HDT,1HGT,1HLT,1HUT,1HXE,1HXF,1ID5,1IHS,1IHT,1JMO,1JOU,1JWT,1K21,1K22,1KTS,1KTT,1LHC,1LHD,1LHE,1LHF,1LHG,1MU6,1MU8,1MUE,1NM6,1NO9,1NRN,1NRO,1NRP,1NRQ,1NRR,1NRS,1NT1,1NU7,1NU9,1NY2,1NZQ,1O0D,1O2G,1O5G,1OOK,1OYT,1P8V,1PPB,1QBV,1QHR,1QJ1,1QJ6,1QJ7,1QUR,1RIW,1SB1,1SL3,1SR5,1T4U,1T4V,1TA2,1TA6,1TB6,1TBZ,1THR,1THS,1TMB,1TMT,1TMU,1TOM,1UMA,1UVS,1W7G,1WAY,1XM1,1XMN,1YPE,1YPG,1YPJ,1YPK,1YPL,1YPM,1Z71,1ZGI,1ZGV,1ZRB,2A2X,2A45,2AFQ,2ANK,2ANM,2B5T,2BDY,2BVR,2BVS,2BVX,2BXT,2BXU,2C8W,2C8X,2C8Y,2C8Z,2C90,2C93,2CF8,2CF9,2CN0,2FEQ,2FES,2GDE,2H9T,2HGT,2HNT,2HPP,2HPQ,2JH0,2JH5,2JH6,2PGQ,2PKS,2PW8,2R2M,2UUF,2UUJ,2UUK,2V3H,2V3O,2ZC9,2ZDA,2ZDV,2ZF0,2ZFF,2ZFP,2ZFQ,2ZFR,2ZG0,2ZGB,2ZGX,2ZHE,2ZHF,2ZHQ,2ZHW,2ZI2,2ZIQ,2ZNK,2ZO3,3B23,3B9F,3BEF,3BF6,3BIU,3BIV,3C1K,3C27,3D49,3DA9,3DD2,3DHK,3DT0,3DUX,3E6P,3EGK,3EQ0,3F68,3GIS,3HAT,3HTC,3K65,3LDX,3LU9,3P17,3P6Z,3P70,3PMH,3PO1,3QLP,3QTO,3QTV,3QWC,3QX5,3RLW,3RLY,3RM0,3RM2,3RML,3RMM,3RMN,3RMO,3SHA,3SHC,3SI3,3SI4,3SV2,3T5F,3TU7,3U69,3U8O,3U8R,3U8T,3U98,3U9A,3UTU,3UWJ,3VXE,3VXF,4AX9,4AYV,4AYY,4AZ2,4BAH,4BAK,4BAM,4BAN,4BAO,4BAQ,4BOH,4CH2,4CH8,4DIH,4DII,4DY7,4E05,4E06,4E7R,4HTC,4I7Y,4LOY,4LXB,4LZ1,4LZ4,4NZQ,4O03,4THN,4UD9,4UDW,4UE7,4UEH,4UFD,4UFE,4UFF,4UFG,4YES,5A2M,5AF9,5AFY,5AFZ,5AHG,5CMX,5DO4,5E8E,5EW1,5EW2,5GDS,5GIM,5JFD,5JZY,5L6N,5LCE,5LPD,5NHU,5TO3,6CYM,6EO6,6EO7,6EO8,6EO9,6EVV,6GBW,6GN7,6GWE,6HSX,6I51,6PX5,6PXJ,6T3M,6T3Q,6T4A,6T52,6T53,6T54,6T55,6T56,6T57,6T7H,6T89,6T8A,6TDT,6TKG,6TKH,6TKI,6TKJ,6TKL,6V5T,6V64,6Y02,6Y9H,6YB6,6YHG,6YHJ,6YMP,6YN3,6YQV,6YSJ,6YSX,6Z48,6Z8V,6Z8W,6Z8X,6ZGO,6ZUG,6ZUH,6ZUN,6ZUU,6ZUW,6ZUX,6ZV7,6ZV8,7AC9,7KME,7MJ5,7NTU,7PHX,7ZKL,7ZKM,7ZKN,7ZKO,8BW5,8KME	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107522	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Neutrophil elastase	Homo sapiens		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	1H1B,1PPF,1PPG,2RG3,2Z7F,3Q76,3Q77,4NZL,4WVP,5A09,5A0A,5A0B,5A0C,5A8X,5A8Y,5A8Z,5ABW,6E69,6F5M,6SMA,7CBK,7WHU,8D4Q,8D4U,8D7I,8D7K,8G24,8G25,8G26	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107523	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Serine protease 1	Homo sapiens		>100000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	1TRN,2RA3,4WWY,7Z9F,8H3S	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107524	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Plasma kallikrein	Human				 3240					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107525	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Coagulation factor X	Homo sapiens		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	1C5M,1EZQ,1F0R,1F0S,1FAX,1FJS,1G2L,1G2M,1HCG,1IOE,1IQE,1IQF,1IQG,1IQH,1IQI,1IQJ,1IQK,1IQL,1IQM,1IQN,1KSN,1LPG,1LPK,1LPZ,1LQD,1MQ5,1MQ6,1NFU,1NFW,1NFX,1NFY,1P0S,1V3X,1WU1,1XKA,1XKB,1Z6E,2BMG,2BOH,2BOK,2BQ6,2BQ7,2BQW,2CJI,2D1J,2EI6,2EI7,2EI8,2FZZ,2G00,2GD4,2H9E,2J2U,2J34,2J38,2J4I,2J94,2J95,2JKH,2P16,2P3F,2P3T,2P3U,2P93,2P94,2P95,2PHB,2PR3,2Q1J,2RA0,2UWL,2UWO,2UWP,2VH0,2VH6,2VVC,2VVU,2VVV,2VWL,2VWM,2VWN,2VWO,2W26,2W3I,2W3K,2WYG,2WYJ,2XBV,2XBW,2XBX,2XBY,2XC0,2XC4,2XC5,2Y5F,2Y5G,2Y5H,2Y7X,2Y7Z,2Y80,2Y81,2Y82,3CEN,3CS7,3ENS,3FFG,3HPT,3IIT,3K9X,3KL6,3KQB,3KQC,3KQD,3KQE,3LIW,3M36,3M37,3Q3K,3SW2,3TK5,3TK6,4A7I,4BTI,4BTT,4BTU,4Y6D,4Y71,4Y76,4Y79,4Y7A,4Y7B,4ZH8,4ZHA,5K0H,5VOE,5VOF,7AHU,7TPP,7TPQ	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107526	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Prothrombin	Human		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	1C1U,1C1V,1C1W,1C4U,1C4V,1C4Y,1C5L,1C5N,1C5O,1CA8,1D3D,1D3P,1D3Q,1D3T,1D4P,1D6W,1D9I,1DE7,1DIT,1DOJ,1DWB,1DWC,1DWD,1DWE,1EB1,1FPC,1FPH,1G30,1G32,1G37,1GHV,1GHW,1GHX,1GHY,1GJ4,1GJ5,1HAG,1HAH,1HAI,1HAO,1HAP,1HBT,1HDT,1HGT,1HLT,1HUT,1HXE,1HXF,1ID5,1IHS,1IHT,1JMO,1JOU,1JWT,1K21,1K22,1KTS,1KTT,1LHC,1LHD,1LHE,1LHF,1LHG,1MU6,1MU8,1MUE,1NM6,1NO9,1NRN,1NRO,1NRP,1NRQ,1NRR,1NRS,1NT1,1NU7,1NU9,1NY2,1NZQ,1O0D,1O2G,1O5G,1OOK,1OYT,1P8V,1PPB,1QBV,1QHR,1QJ1,1QJ6,1QJ7,1QUR,1RIW,1SB1,1SL3,1SR5,1T4U,1T4V,1TA2,1TA6,1TB6,1TBZ,1THR,1THS,1TMB,1TMT,1TMU,1TOM,1UMA,1UVS,1W7G,1WAY,1XM1,1XMN,1YPE,1YPG,1YPJ,1YPK,1YPL,1YPM,1Z71,1ZGI,1ZGV,1ZRB,2A2X,2A45,2AFQ,2ANK,2ANM,2B5T,2BDY,2BVR,2BVS,2BVX,2BXT,2BXU,2C8W,2C8X,2C8Y,2C8Z,2C90,2C93,2CF8,2CF9,2CN0,2FEQ,2FES,2GDE,2H9T,2HGT,2HNT,2HPP,2HPQ,2JH0,2JH5,2JH6,2PGQ,2PKS,2PW8,2R2M,2UUF,2UUJ,2UUK,2V3H,2V3O,2ZC9,2ZDA,2ZDV,2ZF0,2ZFF,2ZFP,2ZFQ,2ZFR,2ZG0,2ZGB,2ZGX,2ZHE,2ZHF,2ZHQ,2ZHW,2ZI2,2ZIQ,2ZNK,2ZO3,3B23,3B9F,3BEF,3BF6,3BIU,3BIV,3C1K,3C27,3D49,3DA9,3DD2,3DHK,3DT0,3DUX,3E6P,3EGK,3EQ0,3F68,3GIS,3HAT,3HTC,3K65,3LDX,3LU9,3P17,3P6Z,3P70,3PMH,3PO1,3QLP,3QTO,3QTV,3QWC,3QX5,3RLW,3RLY,3RM0,3RM2,3RML,3RMM,3RMN,3RMO,3SHA,3SHC,3SI3,3SI4,3SV2,3T5F,3TU7,3U69,3U8O,3U8R,3U8T,3U98,3U9A,3UTU,3UWJ,3VXE,3VXF,4AX9,4AYV,4AYY,4AZ2,4BAH,4BAK,4BAM,4BAN,4BAO,4BAQ,4BOH,4CH2,4CH8,4DIH,4DII,4DY7,4E05,4E06,4E7R,4HTC,4I7Y,4LOY,4LXB,4LZ1,4LZ4,4NZQ,4O03,4THN,4UD9,4UDW,4UE7,4UEH,4UFD,4UFE,4UFF,4UFG,4YES,5A2M,5AF9,5AFY,5AFZ,5AHG,5CMX,5DO4,5E8E,5EW1,5EW2,5GDS,5GIM,5JFD,5JZY,5L6N,5LCE,5LPD,5NHU,5TO3,6CYM,6EO6,6EO7,6EO8,6EO9,6EVV,6GBW,6GN7,6GWE,6HSX,6I51,6PX5,6PXJ,6T3M,6T3Q,6T4A,6T52,6T53,6T54,6T55,6T56,6T57,6T7H,6T89,6T8A,6TDT,6TKG,6TKH,6TKI,6TKJ,6TKL,6V5T,6V64,6Y02,6Y9H,6YB6,6YHG,6YHJ,6YMP,6YN3,6YQV,6YSJ,6YSX,6Z48,6Z8V,6Z8W,6Z8X,6ZGO,6ZUG,6ZUH,6ZUN,6ZUU,6ZUW,6ZUX,6ZV7,6ZV8,7AC9,7KME,7MJ5,7NTU,7PHX,7ZKL,7ZKM,7ZKN,7ZKO,8BW5,8KME	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107527	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Neutrophil elastase	Homo sapiens		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	1H1B,1PPF,1PPG,2RG3,2Z7F,3Q76,3Q77,4NZL,4WVP,5A09,5A0A,5A0B,5A0C,5A8X,5A8Y,5A8Z,5ABW,6E69,6F5M,6SMA,7CBK,7WHU,8D4Q,8D4U,8D7I,8D7K,8G24,8G25,8G26	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107528	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Serine protease 1	Homo sapiens		>100000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	1TRN,2RA3,4WWY,7Z9F,8H3S	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107529	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Plasma kallikrein	Human				 15.0					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107530	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Coagulation factor X	Homo sapiens		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	1C5M,1EZQ,1F0R,1F0S,1FAX,1FJS,1G2L,1G2M,1HCG,1IOE,1IQE,1IQF,1IQG,1IQH,1IQI,1IQJ,1IQK,1IQL,1IQM,1IQN,1KSN,1LPG,1LPK,1LPZ,1LQD,1MQ5,1MQ6,1NFU,1NFW,1NFX,1NFY,1P0S,1V3X,1WU1,1XKA,1XKB,1Z6E,2BMG,2BOH,2BOK,2BQ6,2BQ7,2BQW,2CJI,2D1J,2EI6,2EI7,2EI8,2FZZ,2G00,2GD4,2H9E,2J2U,2J34,2J38,2J4I,2J94,2J95,2JKH,2P16,2P3F,2P3T,2P3U,2P93,2P94,2P95,2PHB,2PR3,2Q1J,2RA0,2UWL,2UWO,2UWP,2VH0,2VH6,2VVC,2VVU,2VVV,2VWL,2VWM,2VWN,2VWO,2W26,2W3I,2W3K,2WYG,2WYJ,2XBV,2XBW,2XBX,2XBY,2XC0,2XC4,2XC5,2Y5F,2Y5G,2Y5H,2Y7X,2Y7Z,2Y80,2Y81,2Y82,3CEN,3CS7,3ENS,3FFG,3HPT,3IIT,3K9X,3KL6,3KQB,3KQC,3KQD,3KQE,3LIW,3M36,3M37,3Q3K,3SW2,3TK5,3TK6,4A7I,4BTI,4BTT,4BTU,4Y6D,4Y71,4Y76,4Y79,4Y7A,4Y7B,4ZH8,4ZHA,5K0H,5VOE,5VOF,7AHU,7TPP,7TPQ	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107531	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Prothrombin	Human		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	1C1U,1C1V,1C1W,1C4U,1C4V,1C4Y,1C5L,1C5N,1C5O,1CA8,1D3D,1D3P,1D3Q,1D3T,1D4P,1D6W,1D9I,1DE7,1DIT,1DOJ,1DWB,1DWC,1DWD,1DWE,1EB1,1FPC,1FPH,1G30,1G32,1G37,1GHV,1GHW,1GHX,1GHY,1GJ4,1GJ5,1HAG,1HAH,1HAI,1HAO,1HAP,1HBT,1HDT,1HGT,1HLT,1HUT,1HXE,1HXF,1ID5,1IHS,1IHT,1JMO,1JOU,1JWT,1K21,1K22,1KTS,1KTT,1LHC,1LHD,1LHE,1LHF,1LHG,1MU6,1MU8,1MUE,1NM6,1NO9,1NRN,1NRO,1NRP,1NRQ,1NRR,1NRS,1NT1,1NU7,1NU9,1NY2,1NZQ,1O0D,1O2G,1O5G,1OOK,1OYT,1P8V,1PPB,1QBV,1QHR,1QJ1,1QJ6,1QJ7,1QUR,1RIW,1SB1,1SL3,1SR5,1T4U,1T4V,1TA2,1TA6,1TB6,1TBZ,1THR,1THS,1TMB,1TMT,1TMU,1TOM,1UMA,1UVS,1W7G,1WAY,1XM1,1XMN,1YPE,1YPG,1YPJ,1YPK,1YPL,1YPM,1Z71,1ZGI,1ZGV,1ZRB,2A2X,2A45,2AFQ,2ANK,2ANM,2B5T,2BDY,2BVR,2BVS,2BVX,2BXT,2BXU,2C8W,2C8X,2C8Y,2C8Z,2C90,2C93,2CF8,2CF9,2CN0,2FEQ,2FES,2GDE,2H9T,2HGT,2HNT,2HPP,2HPQ,2JH0,2JH5,2JH6,2PGQ,2PKS,2PW8,2R2M,2UUF,2UUJ,2UUK,2V3H,2V3O,2ZC9,2ZDA,2ZDV,2ZF0,2ZFF,2ZFP,2ZFQ,2ZFR,2ZG0,2ZGB,2ZGX,2ZHE,2ZHF,2ZHQ,2ZHW,2ZI2,2ZIQ,2ZNK,2ZO3,3B23,3B9F,3BEF,3BF6,3BIU,3BIV,3C1K,3C27,3D49,3DA9,3DD2,3DHK,3DT0,3DUX,3E6P,3EGK,3EQ0,3F68,3GIS,3HAT,3HTC,3K65,3LDX,3LU9,3P17,3P6Z,3P70,3PMH,3PO1,3QLP,3QTO,3QTV,3QWC,3QX5,3RLW,3RLY,3RM0,3RM2,3RML,3RMM,3RMN,3RMO,3SHA,3SHC,3SI3,3SI4,3SV2,3T5F,3TU7,3U69,3U8O,3U8R,3U8T,3U98,3U9A,3UTU,3UWJ,3VXE,3VXF,4AX9,4AYV,4AYY,4AZ2,4BAH,4BAK,4BAM,4BAN,4BAO,4BAQ,4BOH,4CH2,4CH8,4DIH,4DII,4DY7,4E05,4E06,4E7R,4HTC,4I7Y,4LOY,4LXB,4LZ1,4LZ4,4NZQ,4O03,4THN,4UD9,4UDW,4UE7,4UEH,4UFD,4UFE,4UFF,4UFG,4YES,5A2M,5AF9,5AFY,5AFZ,5AHG,5CMX,5DO4,5E8E,5EW1,5EW2,5GDS,5GIM,5JFD,5JZY,5L6N,5LCE,5LPD,5NHU,5TO3,6CYM,6EO6,6EO7,6EO8,6EO9,6EVV,6GBW,6GN7,6GWE,6HSX,6I51,6PX5,6PXJ,6T3M,6T3Q,6T4A,6T52,6T53,6T54,6T55,6T56,6T57,6T7H,6T89,6T8A,6TDT,6TKG,6TKH,6TKI,6TKJ,6TKL,6V5T,6V64,6Y02,6Y9H,6YB6,6YHG,6YHJ,6YMP,6YN3,6YQV,6YSJ,6YSX,6Z48,6Z8V,6Z8W,6Z8X,6ZGO,6ZUG,6ZUH,6ZUN,6ZUU,6ZUW,6ZUX,6ZV7,6ZV8,7AC9,7KME,7MJ5,7NTU,7PHX,7ZKL,7ZKM,7ZKN,7ZKO,8BW5,8KME	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107532	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Neutrophil elastase	Homo sapiens		>10000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	1H1B,1PPF,1PPG,2RG3,2Z7F,3Q76,3Q77,4NZL,4WVP,5A09,5A0A,5A0B,5A0C,5A8X,5A8Y,5A8Z,5ABW,6E69,6F5M,6SMA,7CBK,7WHU,8D4Q,8D4U,8D7I,8D7K,8G24,8G25,8G26	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107533	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Serine protease 1	Homo sapiens		>100000							US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	1TRN,2RA3,4WWY,7Z9F,8H3S	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107534	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18-/m1/s1	LLPPLVKHKYCFMU-RVKKMQEKSA-N	524404	2-((2R,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 1	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465135	461688801							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107535	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18-/m1/s1	LLPPLVKHKYCFMU-IIDMSEBBSA-N	524405	2-((2R,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((R)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 2	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465076	461688802							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107536	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18+/m0/s1	JYHRVUUCZYFFGN-MAUKXSAKSA-N	524406	2-((R)-1-(6-Chloroimidazo[1,2-a]pyridine-2-carbonyl)pyrrolidin-2-yl)-N—((S)-6-guanidino-1-(methylamino)-1-oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 3	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473003	461688803							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107537	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m1/s1	JYHRVUUCZYFFGN-CRAIPNDOSA-N	524407	US11168083, Example 4	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473144	461688804							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107538	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](CN1C(=O)c1cn2cc(Cl)ccc2n1)NC(C)=O	InChI=1S/C26H33ClN10O4S/c1-14(38)32-16-9-20(37(11-16)25(41)18-12-36-10-15(27)6-7-21(36)33-18)24-35-19(13-42-24)23(40)34-17(22(39)30-2)5-3-4-8-31-26(28)29/h6-7,10,12-13,16-17,20H,3-5,8-9,11H2,1-2H3,(H,30,39)(H,32,38)(H,34,40)(H4,28,29,31)/t16-,17+,20-/m1/s1	ZMMPESRTVFDXKA-FUHIMQAGSA-N	524408	2-((2R,4R)-4-acetamido-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 5	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464955	461688805							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107539	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18+/m0/s1	LLPPLVKHKYCFMU-RLFYNMQTSA-N	524409	2-((2R,4S)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 6	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465082	461688806							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107540	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18+/m0/s1	GFAFFEOPNBYDEZ-RLFYNMQTSA-N	524410	US11168083, Example 7	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465029	461688807							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107541	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15+,18+/m0/s1	GFAFFEOPNBYDEZ-HDMKZQKVSA-N	524411	US11168083, Example 8	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473024	461688808							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107542	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15+,18-/m1/s1	GFAFFEOPNBYDEZ-RVKKMQEKSA-N	524412	US11168083, Example 9	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465145	461688809							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107543	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18-/m1/s1	GFAFFEOPNBYDEZ-IIDMSEBBSA-N	524413	US11168083, Example 10	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464993	461688810							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107544	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	LLPPLVKHKYCFMU-VKJFTORMSA-N	524401	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(mcthylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 11	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465010	461688798							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107545	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18+/m1/s1	LLPPLVKHKYCFMU-RKVPGOIHSA-N	524414	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((R)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 12::US11168083, Example 57	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465120	461688811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107546	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2ccccc2n1	InChI=1S/C24H32N10O3S/c1-28-20(35)15(6-2-4-8-29-24(26)27)31-21(36)17-13-38-22(32-17)18-10-14(25)11-34(18)23(37)16-12-33-9-5-3-7-19(33)30-16/h3,5,7,9,12-15,18H,2,4,6,8,10-11,25H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t14-,15+,18+/m1/s1	IQXORBRTZBSKJQ-VKJFTORMSA-N	524415	2-((2S,4R)-4-amino-1-(imidazo[1,2- a]pyridine-2-carbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamide::US11168083, Example 13	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465046	461688812							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107547	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn(C)c(C)n1	InChI=1S/C22H34N10O3S/c1-12-28-15(10-31(12)3)21(35)32-9-13(23)8-17(32)20-30-16(11-36-20)19(34)29-14(18(33)26-2)6-4-5-7-27-22(24)25/h10-11,13-14,17H,4-9,23H2,1-3H3,(H,26,33)(H,29,34)(H4,24,25,27)/t13-,14+,17+/m1/s1	OMCCBPSINYKNOP-KEYYUXOJSA-N	524416	2-((2S,4R)-4-amino-1-(1,2-dimethyl- 1H-imidazole-4-carbonyl)pyrrolidin-2- yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 14	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465111	461688813							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107548	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccccc1	InChI=1S/C23H32N8O3S/c1-27-19(32)16(9-5-6-10-28-23(25)26)29-20(33)17-13-35-21(30-17)18-11-15(24)12-31(18)22(34)14-7-3-2-4-8-14/h2-4,7-8,13,15-16,18H,5-6,9-12,24H2,1H3,(H,27,32)(H,29,33)(H4,25,26,28)/t15-,16+,18+/m1/s1	OCYCSLVKSPDLTL-RYRKJORJSA-N	524417	2-((2S,4R)-4-amino-1- benzoylpyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 15	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465048	461688814							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107549	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)OCc1cccc(Cl)c1	InChI=1S/C24H33ClN8O4S/c1-29-20(34)17(7-2-3-8-30-23(27)28)31-21(35)18-13-38-22(32-18)19-10-16(26)11-33(19)24(36)37-12-14-5-4-6-15(25)9-14/h4-6,9,13,16-17,19H,2-3,7-8,10-12,26H2,1H3,(H,29,34)(H,31,35)(H4,27,28,30)/t16-,17+,19+/m1/s1	PEWLWWZHNVFXPW-AOIWGVFYSA-N	524418	3-chlorobenzyl (2S,4R)-4-amino-2-(4- (((S)-6-guanidino-1-(methylamino)-1- oxohexan-2-yl)carbamoyl)thiazol-2- yl)pyrrolidine-1-carboxylate::US11168083, Example 16	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473046	461688815							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107550	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C1CCCCC1	InChI=1S/C23H38N8O3S/c1-27-19(32)16(9-5-6-10-28-23(25)26)29-20(33)17-13-35-21(30-17)18-11-15(24)12-31(18)22(34)14-7-3-2-4-8-14/h13-16,18H,2-12,24H2,1H3,(H,27,32)(H,29,33)(H4,25,26,28)/t15-,16+,18+/m1/s1	RAUVCEYTYCBNGN-RYRKJORJSA-N	524419	2-((2S,4R)-4-amino-l- (cyclohexanecarbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamidc::US11168083, Example 17	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465035	461688816							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107551	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C(C)C	InChI=1S/C20H34N8O3S/c1-11(2)19(31)28-9-12(21)8-15(28)18-27-14(10-32-18)17(30)26-13(16(29)24-3)6-4-5-7-25-20(22)23/h10-13,15H,4-9,21H2,1-3H3,(H,24,29)(H,26,30)(H4,22,23,25)/t12-,13+,15+/m1/s1	KSHXZRSWQOKILX-IPYPFGDCSA-N	524420	2-((2S,4R)-4-amino-1- isobutyrylpyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 18	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465126	461688817							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107552	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(ccc2n1)C(F)(F)F	InChI=1S/C25H31F3N10O3S/c1-32-20(39)15(4-2-3-7-33-24(30)31)35-21(40)17-12-42-22(36-17)18-8-14(29)10-38(18)23(41)16-11-37-9-13(25(26,27)28)5-6-19(37)34-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,29H2,1H3,(H,32,39)(H,35,40)(H4,30,31,33)/t14-,15+,18+/m1/s1	KOVNKSCBSLWDLG-VKJFTORMSA-N	524421	2-((2S,4R)-4-amino-1-(6- (trifluoromethyl)imidazo[1,2- a]pyridine-2-carbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamide::US11168083, Example 19	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465117	461688818							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107553	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(OC)ccc2n1	InChI=1S/C25H34N10O4S/c1-29-21(36)16(5-3-4-8-30-25(27)28)32-22(37)18-13-40-23(33-18)19-9-14(26)10-35(19)24(38)17-12-34-11-15(39-2)6-7-20(34)31-17/h6-7,11-14,16,19H,3-5,8-10,26H2,1-2H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,16+,19+/m1/s1	HZBXWCRJRXMOSH-ALKREAHSSA-N	524422	2-((2S,4R)-4-amino-1-(6- methoxyimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 20	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465115	461688819							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107554	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(I)ccc2n1	InChI=1S/C24H31IN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15+,18+/m1/s1	RIBQIUQETAVSCK-VKJFTORMSA-N	524423	2-((2S,4R)-4-amino-1-(6- iodoimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 21	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465058	461688820							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107555	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)N[C@@H](CCCCNC(N)=N)C(N)=O	InChI=1S/C23H29ClN10O3S/c24-12-4-5-18-30-15(10-33(18)8-12)22(37)34-9-13(25)7-17(34)21-32-16(11-38-21)20(36)31-14(19(26)35)3-1-2-6-29-23(27)28/h4-5,8,10-11,13-14,17H,1-3,6-7,9,25H2,(H2,26,35)(H,31,36)(H4,27,28,29)/t13-,14+,17+/m1/s1	YGODCUSSYXRBRZ-KEYYUXOJSA-N	524424	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-1- amino-6-guanidino-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 22	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464973	461688821							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107556	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)N[C@@H](CCCCNC(N)=N)C(O)=O	InChI=1S/C23H28ClN9O4S/c24-12-4-5-18-29-15(10-32(18)8-12)21(35)33-9-13(25)7-17(33)20-31-16(11-38-20)19(34)30-14(22(36)37)3-1-2-6-28-23(26)27/h4-5,8,10-11,13-14,17H,1-3,6-7,9,25H2,(H,30,34)(H,36,37)(H4,26,27,28)/t13-,14+,17+/m1/s1	KXJUMARQSGTPDT-KEYYUXOJSA-N	524425	N2-(2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carbonyl)-N6-carbamimidoyl-L-lysine::US11168083, Example 23	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465110	461688822							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107557	CN(C)C(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C25H33ClN10O3S/c1-34(2)23(38)16(5-3-4-8-30-25(28)29)32-21(37)18-13-40-22(33-18)19-9-15(27)11-36(19)24(39)17-12-35-10-14(26)6-7-20(35)31-17/h6-7,10,12-13,15-16,19H,3-5,8-9,11,27H2,1-2H3,(H,32,37)(H4,28,29,30)/t15-,16+,19+/m1/s1	BPUYBKGHVHAYKC-GJYPPUQNSA-N	524426	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-1- (dimcthylamino)-6-guanidino-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 24	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465101	461688823							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107558	CNC(=O)[C@H](CCCCN)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C23H29ClN8O3S/c1-27-20(33)15(4-2-3-7-25)29-21(34)17-12-36-22(30-17)18-8-14(26)10-32(18)23(35)16-11-31-9-13(24)5-6-19(31)28-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,25-26H2,1H3,(H,27,33)(H,29,34)/t14-,15+,18+/m1/s1	IQKGPQDSABYVQE-VKJFTORMSA-N	524427	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- amino-1-(methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 25	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465057	461688824							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107559	CNC(=O)[C@H](CCCCNC(C)=O)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C25H31ClN8O4S/c1-14(35)29-8-4-3-5-17(22(36)28-2)31-23(37)19-13-39-24(32-19)20-9-16(27)11-34(20)25(38)18-12-33-10-15(26)6-7-21(33)30-18/h6-7,10,12-13,16-17,20H,3-5,8-9,11,27H2,1-2H3,(H,28,36)(H,29,35)(H,31,37)/t16-,17+,20+/m1/s1	QREFANRJXDCKQV-UWVAXJGDSA-N	524428	N-((S)-6-acetamido-1-(methylamino)- 1-oxohexan-2-yl)-2-((2S,4R)-4-amino- 1-(6-chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 26	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465095	461688825					C04149		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107560	CNC(=O)[C@H](CCCCNC(N)=O)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(35)15(4-2-3-7-29-24(27)38)31-21(36)17-12-39-22(32-17)18-8-14(26)10-34(18)23(37)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,28,35)(H,31,36)(H3,27,29,38)/t14-,15+,18+/m1/s1	KIXZDQAGELDAQB-VKJFTORMSA-N	524429	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-1- (methylamino)-1-oxo-6-ureidohexan-2- yl)thiazole-4-carboxamidc::US11168083, Example 27	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465020	461688826							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107561	CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C23H29ClN10O3S/c1-28-19(35)14(3-2-6-29-23(26)27)31-20(36)16-11-38-21(32-16)17-7-13(25)9-34(17)22(37)15-10-33-8-12(24)4-5-18(33)30-15/h4-5,8,10-11,13-14,17H,2-3,6-7,9,25H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t13-,14+,17+/m1/s1	UGKMOJZOTINLEE-KEYYUXOJSA-N	524430	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-5- guanidino-1-(methylamino)-1- oxopentan-2-yl)thiazole-4-carboxamide::US11168083, Example 28	Plasma kallikrein	Human				 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465136	461688827							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107562	CNC(=O)[C@H](CCC(N)=O)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C22H25ClN8O4S/c1-26-19(33)13(3-4-17(25)32)28-20(34)15-10-36-21(29-15)16-6-12(24)8-31(16)22(35)14-9-30-7-11(23)2-5-18(30)27-14/h2,5,7,9-10,12-13,16H,3-4,6,8,24H2,1H3,(H2,25,32)(H,26,33)(H,28,34)/t12-,13+,16+/m1/s1	VCKGTIQQFDCCCA-WWGRRREGSA-N	524431	(S)-2-(2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridinc-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamido)-N1- methylpentanediamide::US11168083, Example 29	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137473028	461688828							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107563	CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1			524432	N-((S)-3-(1H-imidazol-4-yl)-1- (methylamino)-1-oxopropan-2-yl)-2- ((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 30	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465100	461688829					C00615		1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107564	CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1			524433	N-((S)-3-(1H-indol-3-yl)-1- (methylamino)-1-oxopropan-2-yl)-2- ((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)thiazole-4- carboxamide::US11168083, Example 31	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465094	461688830							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107565	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C26H26ClN7O4S/c1-29-23(36)18(8-14-2-5-17(35)6-3-14)31-24(37)20-13-39-25(32-20)21-9-16(28)11-34(21)26(38)19-12-33-10-15(27)4-7-22(33)30-19/h2-7,10,12-13,16,18,21,35H,8-9,11,28H2,1H3,(H,29,36)(H,31,37)/t16-,18+,21+/m1/s1	DCRZJWUVOAVWGB-MMOPVJDHSA-N	524434	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-3-(4- hydroxyphenyl)-1-(methylamino)-1- oxopropan-2-yl)thiazole-4- carboxamide::US11168083, Example 32	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465106	461688831							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107566	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18-/m0/s1	JYHRVUUCZYFFGN-YJBOKZPZSA-N	524402	US11168083, Example 33	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464944	461688799							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107567	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1CCCN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O3S/c1-28-20(35)15(5-2-3-9-29-24(26)27)31-21(36)17-13-38-22(32-17)18-6-4-10-34(18)23(37)16-12-33-11-14(25)7-8-19(33)30-16/h7-8,11-13,15,18H,2-6,9-10H2,1H3,(H,28,35)(H,31,36)(H4,26,27,29)/t15-,18+/m1/s1	JYHRVUUCZYFFGN-QAPCUYQASA-N	524435	US11168083, Example 34	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465151	461688832							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107568	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@H](CN1C(=O)c1cn2cc(Cl)ccc2n1)NC(C)=O	InChI=1S/C26H33ClN10O4S/c1-14(38)32-16-9-20(37(11-16)25(41)18-12-36-10-15(27)6-7-21(36)33-18)24-35-19(13-42-24)23(40)34-17(22(39)30-2)5-3-4-8-31-26(28)29/h6-7,10,12-13,16-17,20H,3-5,8-9,11H2,1-2H3,(H,30,39)(H,32,38)(H,34,40)(H4,28,29,31)/t16-,17+,20+/m1/s1	ZMMPESRTVFDXKA-UWVAXJGDSA-N	524436	2-((2S,4R)-4-acetamido-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohcxan-2-yl)thiazole-4-carboxamide::US11168083, Example 35	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464924	461688833							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107569	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18-/m0/s1	LLPPLVKHKYCFMU-MPGHIAIKSA-N	524437	2-((2S,4S)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 36	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465103	461688834							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107570	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18-/m0/s1	GFAFFEOPNBYDEZ-MPGHIAIKSA-N	524438	US11168083, Example 37	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524438	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465037	461688835							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107571	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15+,18+/m1/s1	GFAFFEOPNBYDEZ-VKJFTORMSA-N	524439	US11168083, Example 38	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524439	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465031	461688836							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107572	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](O)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H30ClN9O4S/c1-28-20(36)15(4-2-3-7-29-24(26)27)31-21(37)17-12-39-22(32-17)18-8-14(35)10-34(18)23(38)16-11-33-9-13(25)5-6-19(33)30-16/h5-6,9,11-12,14-15,18,35H,2-4,7-8,10H2,1H3,(H,28,36)(H,31,37)(H4,26,27,29)/t14-,15-,18+/m1/s1	GFAFFEOPNBYDEZ-RKVPGOIHSA-N	524440	US11168083, Example 39	Plasma kallikrein	Human				 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524440	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465036	461688837							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107573	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2ccccc2c1	InChI=1S/C27H34N8O3S/c1-31-23(36)20(8-4-5-11-32-27(29)30)33-24(37)21-15-39-25(34-21)22-13-19(28)14-35(22)26(38)18-10-9-16-6-2-3-7-17(16)12-18/h2-3,6-7,9-10,12,15,19-20,22H,4-5,8,11,13-14,28H2,1H3,(H,31,36)(H,33,37)(H4,29,30,32)/t19-,20+,22+/m1/s1	BXOSIXVQJVFKRG-URVUXULASA-N	524441	2-((2S,4R)-1-(2-naphthoyl)-4- aminopyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 40	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464976	461688838							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107574	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2ncc(Cl)cc2c1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)19(4-2-3-7-32-26(29)30)34-23(38)20-13-40-24(35-20)21-10-17(28)12-36(21)25(39)14-5-6-18-15(8-14)9-16(27)11-33-18/h5-6,8-9,11,13,17,19,21H,2-4,7,10,12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t17-,19+,21+/m1/s1	JBGMLHNBLWKMJG-LMNJBCLMSA-N	524442	2-((2S,4R)-4-amino-1-(3- chloroquinoline-6-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 41	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524442&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465061	461688839							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107575	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2cc(Cl)ccc2n1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)18(4-2-3-9-32-26(29)30)34-23(38)20-13-40-24(35-20)21-11-16(28)12-36(21)25(39)19-7-5-14-10-15(27)6-8-17(14)33-19/h5-8,10,13,16,18,21H,2-4,9,11-12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t16-,18+,21+/m1/s1	GEJBSTPNTAGZPN-MMOPVJDHSA-N	524443	2-((2S,4R)-4-amino-1-(6- chloroquinoline-2-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 42	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524443&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465065	461688840							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107576	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2c(Cl)csc2c1	InChI=1S/C25H31ClN8O3S2/c1-30-21(35)17(4-2-3-7-31-25(28)29)32-22(36)18-12-39-23(33-18)19-9-14(27)10-34(19)24(37)13-5-6-15-16(26)11-38-20(15)8-13/h5-6,8,11-12,14,17,19H,2-4,7,9-10,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t14-,17+,19+/m1/s1	MBWBDEMKWGRUJD-LJHODMEESA-N	524444	2-((2S,4R)-4-amino-1-(3- chlorobenzo[b]thiophene-6- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 43	Plasma kallikrein	Human				 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524444	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524444&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464961	461688841							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107577	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C1=CC2C=C(Cl)C=CC2S1	InChI=1S/C25H33ClN8O3S2/c1-30-21(35)16(4-2-3-7-31-25(28)29)32-22(36)17-12-38-23(33-17)18-10-15(27)11-34(18)24(37)20-9-13-8-14(26)5-6-19(13)39-20/h5-6,8-9,12-13,15-16,18-19H,2-4,7,10-11,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t13?,15-,16+,18+,19?/m1/s1	SNNFYFCMCOGUQV-HHOPHQQQSA-N	524445	2-((2S,4R)-4-amino-1-(5- chlorobenzo[b]thiophcne-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohcxan-2-yl)thiazole-4-carboxamide::US11168083, Example 44	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524445	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524445&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155020634	461688842							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107578	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)C1=NC2C=C(Cl)C=CC2S1	InChI=1S/C24H32ClN9O3S2/c1-29-19(35)14(4-2-3-7-30-24(27)28)31-20(36)16-11-38-21(33-16)17-9-13(26)10-34(17)23(37)22-32-15-8-12(25)5-6-18(15)39-22/h5-6,8,11,13-15,17-18H,2-4,7,9-10,26H2,1H3,(H,29,35)(H,31,36)(H4,27,28,30)/t13-,14+,15?,17+,18?/m1/s1	GJGFBTQCJROWAU-UFKRDZGPSA-N	524446	2-((2S,4R)-4-amino-1-(5- chlorobenzo[d]thiazole-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 45	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524446	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524446&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			155020626	461688843							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107579	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCCCCCNC(N)=N	InChI=1S/C22H28ClN9O2S/c23-13-4-5-18-29-15(11-31(18)9-13)21(34)32-10-14(24)8-17(32)20-30-16(12-35-20)19(33)27-6-2-1-3-7-28-22(25)26/h4-5,9,11-12,14,17H,1-3,6-8,10,24H2,(H,27,33)(H4,25,26,28)/t14-,17+/m1/s1	KBCPCNVORWUACK-PBHICJAKSA-N	524447	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(5- guanidinopentyl)thiazole-4- carboxamide::US11168083, Example 46	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524447	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524447&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465077	461688844							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107580	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ccc(cc1)C(N)=N	InChI=1S/C24H23ClN8O2S/c25-15-5-6-20-30-17(11-32(20)9-15)24(35)33-10-16(26)7-19(33)23-31-18(12-36-23)22(34)29-8-13-1-3-14(4-2-13)21(27)28/h1-6,9,11-12,16,19H,7-8,10,26H2,(H3,27,28)(H,29,34)/t16-,19+/m1/s1	ISBGVOZOKHEQDV-APWZRJJASA-N	524448	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(4- carbamimidoylbenzyl)thiazole-4- carboxamide::US11168083, Example 47	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524448	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524448&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465056	461688845							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107581	Cc1cc(N)nc(C)c1CNC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H25ClN8O2S/c1-12-5-20(27)29-13(2)16(12)7-28-22(34)18-11-36-23(31-18)19-6-15(26)9-33(19)24(35)17-10-32-8-14(25)3-4-21(32)30-17/h3-5,8,10-11,15,19H,6-7,9,26H2,1-2H3,(H2,27,29)(H,28,34)/t15-,19+/m1/s1	NIKWDISSLUKVAJ-BEFAXECRSA-N	524449	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((6-amino- 2,4-dimethylpyridin-3- yl)methyl)thiazole-4-carboxamide::US11168083, Example 48	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524449	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524449&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465043	461688846							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107582	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ccc2c(N)nccc2c1	InChI=1S/C26H23ClN8O2S/c27-16-2-4-22-32-19(12-34(22)10-16)26(37)35-11-17(28)8-21(35)25-33-20(13-38-25)24(36)31-9-14-1-3-18-15(7-14)5-6-30-23(18)29/h1-7,10,12-13,17,21H,8-9,11,28H2,(H2,29,30)(H,31,36)/t17-,21+/m1/s1	SYUKSGXOSHFNNI-UTKZUKDTSA-N	524450	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((1- aminoisoquinolin-6-yl)methyl)thiazole- 4-carboxamide::US11168083, Example 49	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524450	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524450&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464965	461688847							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107583	NCc1ccc(CNC(=O)c2csc(n2)[C@@H]2C[C@@H](N)CN2C(=O)c2cn3cc(Cl)ccc3n2)cc1	InChI=1S/C24H24ClN7O2S/c25-16-5-6-21-29-18(12-31(21)10-16)24(34)32-11-17(27)7-20(32)23-30-19(13-35-23)22(33)28-9-15-3-1-14(8-26)2-4-15/h1-6,10,12-13,17,20H,7-9,11,26-27H2,(H,28,33)/t17-,20+/m1/s1	FHGGDJNWGJXNMM-XLIONFOSSA-N	524451	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(4- (aminomethyl)benzyl)thiazole-4- carboxamide::US11168083, Example 50	Plasma kallikrein	Human				 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524451	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524451&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465052	461688848							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107584	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCCc1ccc(cc1)C(N)=N	InChI=1S/C25H25ClN8O2S/c26-16-5-6-21-31-18(12-33(21)10-16)25(36)34-11-17(27)9-20(34)24-32-19(13-37-24)23(35)30-8-7-14-1-3-15(4-2-14)22(28)29/h1-6,10,12-13,17,20H,7-9,11,27H2,(H3,28,29)(H,30,35)/t17-,20+/m1/s1	VMZMWVBYMSGTPQ-XLIONFOSSA-N	524452	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(4- carbamimidoylphenethyl)thiazole-4- carboxamide::US11168083, Example 51	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524452	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524452&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464984	461688849							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107585	Cc1cc(N)nc(C)c1CCNC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C25H27ClN8O2S/c1-13-7-21(28)30-14(2)17(13)5-6-29-23(35)19-12-37-24(32-19)20-8-16(27)10-34(20)25(36)18-11-33-9-15(26)3-4-22(33)31-18/h3-4,7,9,11-12,16,20H,5-6,8,10,27H2,1-2H3,(H2,28,30)(H,29,35)/t16-,20+/m1/s1	LSDUXDLFSXDPQA-UZLBHIALSA-N	524453	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(2-(6- amino-2,4-dimethylpyridin-3- yl)ethyl)thiazole-4-carboxamide::US11168083, Example 52	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524453&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465062	461688850							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107586	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCCc1ccc2c(N)nccc2c1	InChI=1S/C27H25ClN8O2S/c28-17-2-4-23-33-20(13-35(23)11-17)27(38)36-12-18(29)10-22(36)26-34-21(14-39-26)25(37)32-7-5-15-1-3-19-16(9-15)6-8-31-24(19)30/h1-4,6,8-9,11,13-14,18,22H,5,7,10,12,29H2,(H2,30,31)(H,32,37)/t18-,22+/m1/s1	GFDKMJFZUDZXRK-GCJKJVERSA-N	524454	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-(2-(1- aminoisoquinolin-6-yl)ethyl)thiazole-4- carboxamide::US11168083, Example 53	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524454	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524454&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464970	461688851							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107587	NCc1ccc(CCNC(=O)c2csc(n2)[C@@H]2C[C@@H](N)CN2C(=O)c2cn3cc(Cl)ccc3n2)cc1	InChI=1S/C25H26ClN7O2S/c26-17-5-6-22-30-19(13-32(22)11-17)25(35)33-12-18(28)9-21(33)24-31-20(14-36-24)23(34)29-8-7-15-1-3-16(10-27)4-2-15/h1-6,11,13-14,18,21H,7-10,12,27-28H2,(H,29,34)/t18-,21+/m1/s1	YUPDPXYEIFAQRA-NQIIRXRSSA-N	524455	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pynolidin-2-yl)-N-(4- (aminomethyl)phenethyl)thiazole-4- carboxamide::US11168083, Example 54	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524455	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524455&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465004	461688852							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107588	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ncn2ccc(Cl)cc12	InChI=1S/C24H20Cl2N8O2S/c25-13-3-4-32-12-29-16(19(32)5-13)7-28-22(35)18-11-37-23(31-18)20-6-15(27)9-34(20)24(36)17-10-33-8-14(26)1-2-21(33)30-17/h1-5,8,10-12,15,20H,6-7,9,27H2,(H,28,35)/t15-,20+/m1/s1	FKQMDAAKAOWPEB-QRWLVFNGSA-N	524403	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((7- chloroimidazo[1,5-a]pyridin-1- yl)methyl)thiazole-4-carboxamide::US11168083, Example 55	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465054	461688800							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107589	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1ccc2cc(Cl)ccc2c1	InChI=1S/C27H22Cl2N6O2S/c28-18-4-3-16-7-15(1-2-17(16)8-18)10-31-25(36)22-14-38-26(33-22)23-9-20(30)12-35(23)27(37)21-13-34-11-19(29)5-6-24(34)32-21/h1-8,11,13-14,20,23H,9-10,12,30H2,(H,31,36)/t20-,23+/m1/s1	UGVFMASJHLZOFK-OFNKIYASSA-N	524456	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((6- chloronaphthalen-2-yl)methyl)thiazole- 4-carboxamide::US11168083, Example 56	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524456	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524456&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465129	461688853							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107590	CNC(=O)[C@@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C24H31ClN10O3S/c1-29-20(36)15(4-2-3-7-30-24(27)28)32-21(37)17-12-39-22(33-17)18-8-14(26)10-35(18)23(38)16-11-34-9-13(25)5-6-19(34)31-16/h5-6,9,11-12,14-15,18H,2-4,7-8,10,26H2,1H3,(H,29,36)(H,32,37)(H4,27,28,30)/t14-,15-,18+/m1/s1	LLPPLVKHKYCFMU-RKVPGOIHSA-N	524414	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((R)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 12::US11168083, Example 57	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524414&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465120	461688811							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107591	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1n[nH]c2ccc(Cl)cc12			524458	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((5-chloro- 1H-indazol-3-yl)methyl)thiazole-4- carboxamide::US11168083, Example 58	Plasma kallikrein	Human				 7500					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524458	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524458&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465067	461688854							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107592	N[C@@H]1C[C@H](N(C1)C(=O)c1cn2cc(Cl)ccc2n1)c1nc(cs1)C(=O)NCc1n[nH]c2cc(Cl)ccc12			524459	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((6-chloro- 1H-indazol-3-yl)methyl)thiazole-4- carboxamide::US11168083, Example 59	Plasma kallikrein	Human				>9900					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524459	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524459&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464948	461688855							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107593	Cc1cc2c(N)nccc2c(C)c1CNC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(Cl)ccc2n1	InChI=1S/C28H27ClN8O2S/c1-14-7-19-18(5-6-32-25(19)31)15(2)20(14)9-33-26(38)22-13-40-27(35-22)23-8-17(30)11-37(23)28(39)21-12-36-10-16(29)3-4-24(36)34-21/h3-7,10,12-13,17,23H,8-9,11,30H2,1-2H3,(H2,31,32)(H,33,38)/t17-,23+/m1/s1	BSTKXPMFPPOUDP-HXOBKFHXSA-N	524460	2-((2S,4R)-4-amino-1-(6- chloroimidazo[1,2-a]pyridine-2- carbonyl)pyrrolidin-2-yl)-N-((1-amino- 5,7-dimethylisoquinolin-6- yl)methyl)thiazole-4-carboxamide::US11168083, Example 60	Plasma kallikrein	Human				<100					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524460	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524460&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465073	461688856							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107594	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2cc(Cl)c(Cl)cc2s1	InChI=1S/C25H30Cl2N8O3S2/c1-31-21(36)16(4-2-3-5-32-25(29)30)33-22(37)17-11-39-23(34-17)18-8-13(28)10-35(18)24(38)20-7-12-6-14(26)15(27)9-19(12)40-20/h6-7,9,11,13,16,18H,2-5,8,10,28H2,1H3,(H,31,36)(H,33,37)(H4,29,30,32)/t13-,16+,18+/m1/s1	FDABKPHXIICLML-SKDZVZGDSA-N	524461	2-((2S,4R)-4-amino-1-(5,6- dichlorobenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 61	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524461	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524461&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465092	461688857							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107595	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2ccc(Cl)cc2s1	InChI=1S/C25H31ClN8O3S2/c1-30-21(35)16(4-2-3-7-31-25(28)29)32-22(36)17-12-38-23(33-17)18-10-15(27)11-34(18)24(37)20-8-13-5-6-14(26)9-19(13)39-20/h5-6,8-9,12,15-16,18H,2-4,7,10-11,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t15-,16+,18+/m1/s1	UCKDBXMZROGZMA-RYRKJORJSA-N	524462	2-((2S,4R)-4-amino-1-(6- chlorobenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 62	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524462	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524462&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465040	461688858							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107596	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2c(Cl)cccc2s1	InChI=1S/C25H31ClN8O3S2/c1-30-21(35)16(6-2-3-8-31-25(28)29)32-22(36)17-12-38-23(33-17)18-9-13(27)11-34(18)24(37)20-10-14-15(26)5-4-7-19(14)39-20/h4-5,7,10,12-13,16,18H,2-3,6,8-9,11,27H2,1H3,(H,30,35)(H,32,36)(H4,28,29,31)/t13-,16+,18+/m1/s1	SNRDAMCHFNCWJG-SKDZVZGDSA-N	524463	2-((2S,4R)-4-amino-1-(4- chlorobenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 63	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524463	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524463&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465081	461688859							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107597	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2cc(ccc2s1)C(F)(F)F	InChI=1S/C26H31F3N8O3S2/c1-33-21(38)16(4-2-3-7-34-25(31)32)35-22(39)17-12-41-23(36-17)18-10-15(30)11-37(18)24(40)20-9-13-8-14(26(27,28)29)5-6-19(13)42-20/h5-6,8-9,12,15-16,18H,2-4,7,10-11,30H2,1H3,(H,33,38)(H,35,39)(H4,31,32,34)/t15-,16+,18+/m1/s1	OZQHKLQLDUISBY-RYRKJORJSA-N	524464	2-((2S,4R)-4-amino-1-(5- (trifluoromethyl)benzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 64	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524464&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137465146	461688860							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107598	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cc2ccc(C)cc2s1	InChI=1S/C26H34N8O3S2/c1-14-6-7-15-10-21(39-20(15)9-14)25(37)34-12-16(27)11-19(34)24-33-18(13-38-24)23(36)32-17(22(35)30-2)5-3-4-8-31-26(28)29/h6-7,9-10,13,16-17,19H,3-5,8,11-12,27H2,1-2H3,(H,30,35)(H,32,36)(H4,28,29,31)/t16-,17+,19+/m1/s1	CBXMSTBUKVKBJV-AOIWGVFYSA-N	524465	2-((2S,4R)-4-amino-1-(6- methylbenzo[b]thiophene-2- carbonyl)pyrrolidin-2-yl)-N-((S)-6- guanidino-1-(methylamino)-1- oxohexan-2-yl)thiazole-4-carboxamide::US11168083, Example 65	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524465&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464945	461688861							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107599	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cnc2ccc(Cl)cc2c1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)19(4-2-3-7-32-26(29)30)34-23(38)20-13-40-24(35-20)21-10-17(28)12-36(21)25(39)15-8-14-9-16(27)5-6-18(14)33-11-15/h5-6,8-9,11,13,17,19,21H,2-4,7,10,12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t17-,19+,21+/m1/s1	MLEJYXYWKYQGTH-LMNJBCLMSA-N	524466	2-((2S,4R)-4-amino-1-(6- chloroquinoline-3-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 66	Plasma kallikrein	Human				 550					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524466&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464987	461688862							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1107600	CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1ccc2nc(Cl)ccc2c1	InChI=1S/C26H32ClN9O3S/c1-31-22(37)18(4-2-3-9-32-26(29)30)34-23(38)19-13-40-24(35-19)20-11-16(28)12-36(20)25(39)15-5-7-17-14(10-15)6-8-21(27)33-17/h5-8,10,13,16,18,20H,2-4,9,11-12,28H2,1H3,(H,31,37)(H,34,38)(H4,29,30,32)/t16-,18+,20+/m1/s1	PBOYRHRFMVZNFR-KPFFTGBYSA-N	524467	2-((2S,4R)-4-amino-1-(2- chloroquinoline-6-carbonyl)pyrrolidin- 2-yl)-N-((S)-6-guanidino-1- (methylamino)-1-oxohexan-2- yl)thiazole-4-carboxamide::US11168083, Example 67	Plasma kallikrein	Human				 3000					US Patent		10.7270/Q2TB1B2X		aid1806072	US11168083	Travins, J; Miller, T; Papaioannou, N	11/9/2021	3/27/2022	Takeda Pharmaceutical Company Limited	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=524467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=524467&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search			137464953	461688863							1	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA	6O1G,6T7P	Plasma kallikrein	KLKB1_HUMAN	P03952	A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3